Advanced search
1 file | 4.71 MB Add to list

Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes

Author
Organization
Abstract
Proteoglycans consist of a core protein substituted with one or more glycosaminoglycan (GAG) chains and execute versatile functions during many physiological and pathological processes. The biosynthesis of GAG chains is a complex process that depends on the concerted action of a variety of enzymes. Central to the biosynthesis of heparan sulfate (HS) and chondroitin sulfate/dermatan sulfate (CS/DS) GAG chains is the formation of a tetrasaccharide linker region followed by biosynthesis of HS or CS/DS-specific repeating di-saccharide units, which then undergo modifications and epimerization. The importance of these biosynthetic enzymes is illustrated by several severe pleiotropic disorders that arise upon their deficiency. The Ehlers-Danlos syndromes (EDS) constitute a special group among these disorders. Although most EDS types are caused by defects in fibrillar types I, III, or V collagen, or their modifying enzymes, a few rare EDS types have recently been linked to defects in GAG biosynthesis. Spondylodysplastic EDS (spEDS) is caused by defective formation of the tetrasaccharide linker region, either due to 134GalT7 or 133GalT6 deficiency, whereas musculocontractural EDS (mcEDS) results from deficiency of D4ST1 or DS-epi1, impairing DS formation. This narrative review highlights the consequences of GAG deficiency in these specific EDS types, summarizes the associated phenotypic features and the molecular spectrum of reported pathogenic variants, and defines the current knowledge on the underlying pathophysiological mechanisms based on studies in patient-derived material, in vitro analyses, and animal models.
Keywords
Cell Biology, Physiology, proteoglycan, glycosaminoglycan, Ehlers-Danlos syndromes, decorin, collagen

Downloads

  • ajpcell.00127.2022.pdf
    • full text (Accepted manuscript)
    • |
    • open access
    • |
    • PDF
    • |
    • 4.71 MB

Citation

Please use this url to cite or link to this publication:

MLA
Syx, Delfien, et al. “Alterations in Glycosaminoglycan Biosynthesis Associated with the Ehlers-Danlos Syndromes.” AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, vol. 323, no. 6, 2022, pp. C1843–59, doi:10.1152/ajpcell.00127.2022.
APA
Syx, D., Delbaere, S., Bui, C., De Clercq, A., Larson, G., Mizumoto, S., … Malfait, F. (2022). Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 323(6), C1843–C1859. https://doi.org/10.1152/ajpcell.00127.2022
Chicago author-date
Syx, Delfien, Sarah Delbaere, Catherine Bui, Adelbert De Clercq, Göran Larson, Shuji Mizumoto, Tomoki Kosho, Sylvie Fournel-Gigleux, and Fransiska Malfait. 2022. “Alterations in Glycosaminoglycan Biosynthesis Associated with the Ehlers-Danlos Syndromes.” AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY 323 (6): C1843–59. https://doi.org/10.1152/ajpcell.00127.2022.
Chicago author-date (all authors)
Syx, Delfien, Sarah Delbaere, Catherine Bui, Adelbert De Clercq, Göran Larson, Shuji Mizumoto, Tomoki Kosho, Sylvie Fournel-Gigleux, and Fransiska Malfait. 2022. “Alterations in Glycosaminoglycan Biosynthesis Associated with the Ehlers-Danlos Syndromes.” AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY 323 (6): C1843–C1859. doi:10.1152/ajpcell.00127.2022.
Vancouver
1.
Syx D, Delbaere S, Bui C, De Clercq A, Larson G, Mizumoto S, et al. Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. 2022;323(6):C1843–59.
IEEE
[1]
D. Syx et al., “Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes,” AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, vol. 323, no. 6, pp. C1843–C1859, 2022.
@article{8770413,
  abstract     = {{Proteoglycans consist of a core protein substituted with one or more glycosaminoglycan (GAG) chains and execute versatile functions during many physiological and pathological processes. The biosynthesis of GAG chains is a complex process that depends on the concerted action of a variety of enzymes. Central to the biosynthesis of heparan sulfate (HS) and chondroitin sulfate/dermatan sulfate (CS/DS) GAG chains is the formation of a tetrasaccharide linker region followed by biosynthesis of HS or CS/DS-specific repeating di-saccharide units, which then undergo modifications and epimerization. The importance of these biosynthetic enzymes is illustrated by several severe pleiotropic disorders that arise upon their deficiency. The Ehlers-Danlos syndromes (EDS) constitute a special group among these disorders. Although most EDS types are caused by defects in fibrillar types I, III, or V collagen, or their modifying enzymes, a few rare EDS types have recently been linked to defects in GAG biosynthesis. Spondylodysplastic EDS (spEDS) is caused by defective formation of the tetrasaccharide linker region, either due to 134GalT7 or 133GalT6 deficiency, whereas musculocontractural EDS (mcEDS) results from deficiency of D4ST1 or DS-epi1, impairing DS formation. This narrative review highlights the consequences of GAG deficiency in these specific EDS types, summarizes the associated phenotypic features and the molecular spectrum of reported pathogenic variants, and defines the current knowledge on the underlying pathophysiological mechanisms based on studies in patient-derived material, in vitro analyses, and animal models.}},
  author       = {{Syx, Delfien and Delbaere, Sarah and Bui, Catherine and De Clercq, Adelbert and Larson, Göran and Mizumoto, Shuji and Kosho, Tomoki and Fournel-Gigleux, Sylvie and Malfait, Fransiska}},
  issn         = {{0363-6143}},
  journal      = {{AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY}},
  keywords     = {{Cell Biology,Physiology,proteoglycan,glycosaminoglycan,Ehlers-Danlos syndromes,decorin,collagen}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{C1843--C1859}},
  title        = {{Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes}},
  url          = {{http://doi.org/10.1152/ajpcell.00127.2022}},
  volume       = {{323}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: